Narelle Hadlow, M. B. B. S. , Suzanne J. Brown, B. Sc

Slides:

Advertisements

Similar presentations

High frequency of discordance between antimüllerian hormone and follicle-stimulating hormone levels in serum from estradiol-confirmed days 2 to 4 of the.

Advertisements

Age-specific serum anti-Müllerian hormone values for 17,120 women presenting to fertility centers within the United States David B. Seifer, M.D., Valerie.

Andrew J. Krentz, M.D., Elizabeth Barrett-Connor, M.D.

Yuqian Cui, M. D. , Ph. D. , Yuhua Shi, M. D. , Ph. D. , Linlin Cui, M

Nicole Banks, M. D. , George Patounakis, M. D. , Ph. D

Variation in circulating antimüllerian hormone precursor during the periovulatory and acute postovulatory phases of the human ovarian cycle Michael W.

Fertility preservation in pre-pubertal girls with cancer: the role of ovarian tissue cryopreservation W. Hamish B. Wallace, M.D., Thomas W. Kelsey, Ph.D.,

Longitudinal changes in maternal serum concentrations of antimüllerian hormone in individual women during conception cycles and early pregnancy Kristina.

Impact of laparoscopic cystectomy on ovarian reserve: serial changes of serum anti- Müllerian hormone levels Hye Jin Chang, M.D., Ph.D., Sang Hoon Han,

Does the time interval between antimüllerian hormone serum sampling and initiation of ovarian stimulation affect its predictive ability in in vitro fertilization–intracytoplasmic.

Antimüllerian hormone levels and numbers and sizes of antral follicles in regularly menstruating women of reproductive age referenced to true ovulation.

Fernando Zegers-Hochschild, M.D. Fertility and Sterility

Jacqueline R. Ho, Wael Salem, Nabil Arrach, Karine Chung, Richard J

Value of the serum estradiol level for preventing ovarian hyperstimulation syndrome: a retrospective case control study Arianna D'Angelo, M.D., Rachel.

Janet Kwee, M. D. , Roel Schats, M. D. , Ph. D. , Joseph McDonnell, M

Distribution of male infertility specialists in relation to the male population and assisted reproductive technology centers in the United States Ajay.

Comparative assessment of five serum antimüllerian hormone assays for the diagnosis of polycystic ovary syndrome Pascal Pigny, Ph.D., Elisse Gorisse,

Role of ovarian reserve markers, antimüllerian hormone and antral follicle count, as aneuploidy markers in ongoing pregnancies and miscarriages Maribel.

Antimüllerian hormone levels and antral follicle count as prognostic indicators in a personalized prediction model of live birth Scott M. Nelson, M.R.C.O.G.,

Antimüllerian hormone as a predictor of live birth following assisted reproduction: an analysis of 85,062 fresh and thawed cycles from the Society for.

A randomized, controlled, pilot trial on the effect of dehydroepiandrosterone on ovarian response markers, ovarian response, and in vitro fertilization.

The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count Simone L. Broer, B.Sc., Ben Willem J.

Biomarkers of ovarian response: current and future applications

Modified natural cycle in in vitro fertilization

Anti-Müllerian hormone: correlation of early follicular, ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm.

Changes in serum anti-Müllerian hormone levels may predict damage to residual normal ovarian tissue after laparoscopic surgery for women with ovarian.

How old is too old? Challenges faced by clinicians concerning age cutoffs for patients undergoing in vitro fertilization Robert L. Klitzman, M.D. Fertility.

Oocyte cryopreservation

Does preoperative antimüllerian hormone level influence postoperative pregnancy rate in women undergoing surgery for severe endometriosis? Emanuela Stochino-Loi,

Cervical mucus removal before embryo transfer in women undergoing in vitro fertilization/intracytoplasmic sperm injection: a systematic review and meta-analysis.

Do anti-mullerian hormone levels predict ovarian reserve in SLE patients presenting for hematopoietic stem cell transplant? H. Browne, A. Armstrong,

Deleterious effect of tobacco on IVF outcome and ovarian reserve as reflected by serum anti mullerian hormone (AMH) P. Barriere, T. Freour, D. Masson,

Modification of the Beckman-Coulter second-generation enzyme-linked immunosorbent assay protocol improves the reliability of serum antimüllerian hormone.

Albert Hsu, M. D. , Margaret Arny, Ph. D. , Alexander B. Knee, M. S

Prospective study into the value of the automated Elecsys antimüllerian hormone assay for the assessment of the ovarian growing follicle pool Richard.

Race/ethnic disparities in reproductive age: an examination of ovarian reserve estimates across four race/ethnic groups of healthy, regularly cycling.

Microdose flare protocol with interrupted follicle stimulating hormone and added androgen for poor responders—an observational pilot study Frederic Mitri,

Association between prior appendectomy and/or tonsillectomy in women and subsequent pregnancy rate: a cohort study Li Wei, Ph.D., Thomas MacDonald, M.D.,

Sean Ackerman, M. D. , Julia Wenegrat, M. A. , David Rettew, M. D

David E. Reichman, M.D., Dan Goldschlag, M.D., Zev Rosenwaks, M.D.

Estimating Genetic Effects and Quantifying Missing Heritability Explained by Identified Rare-Variant Associations Dajiang J. Liu, Suzanne M. Leal The.

From partner's desk to iPad

Fertility and Sterility

Antimüllerian hormone as predictor of implantation and clinical pregnancy after assisted conception: a systematic review and meta-analysis Reshef Tal,

Comparison of antimüllerian hormone levels and antral follicle count as predictor of ovarian response to controlled ovarian stimulation in good-prognosis.

Clomiphene citrate at 50: the dawning of assisted reproduction

Akanksha Mehta, M.D., Darius A. Paduch, M.D., Ph.D.

Follicle-stimulating hormone or human menopausal gonadotropin for ovarian stimulation in in vitro fertilization cycles: a meta-analysis Rina Agrawal,

Anti-Müllerian hormone and inhibin B as predictors of pregnancy after treatment by in vitro fertilization/intracytoplasmic sperm injection Dorothea M.

Changes in cytokine levels of patients with ovarian endometriosis after treatment with gonadotropin-releasing hormone analogue, ultrasound-guided drainage,

Clinical and endocrine response to the withdrawal of gonadotropin-releasing hormone agonists during prolonged coasting Basil Ho Yuen, M.B., Ch.B., Tuan-Anh.

A retrospective study on the use of dose-dependent letrozole to decrease cancer recurrence and adverse events in patients undergoing ovarian stimulation

MaryFran Sowers, Ph. D. , Daniel McConnell, Ph. D

Vasiliki A. Moragianni, M. D. , M. S. , Stephanie-Marie L. Jones, M. D

Decline of serum antimüllerian hormone levels after laparoscopic ovarian cystectomy in endometrioma and other benign cysts: a prospective cohort study

Stephanie A. Beall, M.D., Ph.D., Alan DeCherney, M.D.

Richard M. Sharpe, Ph.D., Niels E. Skakkebaek, M.D.

Fertility and Sterility: an evaluation

Clinical and biologic evaluation of ovarian function in women treated by bone marrow transplantation for various indications during childhood or adolescence

Nomogram for the decline in serum antimüllerian hormone: a population study of 9,601 infertility patients Scott M. Nelson, Ph.D., Martina C. Messow,

Follicular fluid of single follicles from women with PCOS contains higher levels of müllerian inhibiting substance L.T. Ku, S.T. Nakajima, M.E. McClure,

Comparing anti-Müllerian hormone (AMH) and follicle-stimulating hormone (FSH) as predictors of ovarian function David H. Barad, M.D., M.S., Andrea Weghofer,

Egg production predicts a doubling of in vitro fertilization pregnancy rates even within defined age and ovarian reserve categories Melissa C. Yih, M.D.,

Divergent effects of the 677C>T mutation of the 5,10-methylenetetrahydrofolate reductase (MTHFR) gene on ovarian responsiveness and anti-Müllerian hormone.

In vitro sildenafil citrate use as a sperm motility stimulant

Hormones, mood, sexuality, and the menopausal transition

Bárbara Oriol, M. D. , Ana Barrio, M. D. , Alberto Pacheco, Ph. D

Anti-Müllerian hormone (AMH) defines, independent of age, low versus good live-birth chances in women with severely diminished ovarian reserve Norbert.

Intrafollicular antimüllerian hormone levels predict follicle responsiveness to follicle- stimulating hormone (FSH) in normoandrogenic ovulatory women.

A prospective, comparative analysis of anti-Müllerian hormone, inhibin-B, and three- dimensional ultrasound determinants of ovarian reserve in the prediction.

Presentation transcript:

Quantifying the intraindividual variation of antimüllerian hormone in the ovarian cycle Narelle Hadlow, M.B.B.S., Suzanne J. Brown, B.Sc., Afsana Habib, M.B.B.S., Robert Wardrop, B.App.Sc., John Joseph, B.Sc., Melissa Gillett, M.B.B.S., Rhonda Maguire, M.B.B.S., Johan Conradie, M.B., Ch.B. Fertility and Sterility Volume 106, Issue 5, Pages 1230-1237 (October 2016) DOI: 10.1016/j.fertnstert.2016.06.009 Copyright © 2016 Terms and Conditions

Figure 1 Components of variation in antimüllerian hormone (AMH) over the range of AMH results. The analytical (CVA%), biological (CVI%), and total variation (CVW%) are shown for increasing mean AMH. Values are plotted at the median AMH of each AMH band: <5 pmol/L, 5–10 pmol/L, >10–30 pmol/L, and > 30 pmol/L. Fertility and Sterility 2016 106, 1230-1237DOI: (10.1016/j.fertnstert.2016.06.009) Copyright © 2016 Terms and Conditions

Figure 2 Variation of antimüllerian hormone (AMH) in individuals for a given mean AMH result. Typical variation of AMH (95% confidence interval based on intraindividual standard deviation averaged within-band) for AMH bands (<5, 5–10, >10–30, >30 pmol/L). Error bars are centered at the median within-band AMH. Fertility and Sterility 2016 106, 1230-1237DOI: (10.1016/j.fertnstert.2016.06.009) Copyright © 2016 Terms and Conditions

Figure 3 Median and range of antimüllerian hormone (AMH) results in each individual. The median and range of results in each woman, displayed in order of ascending median AMH. The dashed lines represent relevant clinical cutoffs (5, 10, and 30 pmol/L). Fertility and Sterility 2016 106, 1230-1237DOI: (10.1016/j.fertnstert.2016.06.009) Copyright © 2016 Terms and Conditions